----
Current ValuationThe current P/E ratio is -21.91, above the reasonable range, cheaper than 14.07% of the time in the past 3 years, and the industry ranks 25/29, the industry Median -0.94.
-21.91xP/E
$0.08Stock price
$-0.00Earnings per share
-21.91xP/E
Stock price$0.08Earnings per share$-0.00
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -25.65x
- Typical range
- -35.93x–-23.30x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
05101520
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
DOWUSDow | -27.29x | 152.94% | $24.70B |
LYBUSLyondellbasell Industries NV | -60.60x | 418.62% | $21.76B |
WLKUSWestlake | -6.79x | 115.89% | $8.35B |
OLNUSOLIN | -9.23x | 100.20% | $1.82B |
ECVTUSEcovyst | -17.54x | -- | $1.08B |
KROUSKronos Worldwide | -8.01x | -- | $875.89M |
KOPUSKoppers | -8.67x | 294.16% | $753.25M |
PCTTUUSPureCycle Tech - Unit | -2.88x | -- | $671.02M |
PCTUSPureCycle Tech | -2.30x | 32.22% | $536.42M |
TROXUSTronox Holdings Plc -Class | -0.94x | 32.32% | $554.16M |
BAKUSBraskem SA | -0.84x | 118.45% | $876.67M |
ASIXUSAdvanSix | -23.56x | 106.67% | $417.71M |
OECUSOrion SA | -3.15x | 74.19% | $303.53M |
KBLBUSKraig Biocraft Laboratories, Inc. | -21.91x | -- | $90.90M |
TANHUSTanTech | -2.54x | -- | $79.86M |
LOOPUSLoop Industries | -1.01x | 7.69% | $12.09M |
GUREUSGulf Resources | -0.12x | -- | $5.10M |
CNEYUSCN Energy | -0.06x | -- | $4.14M |
TSEOQUSTRINSEO PLC | -0.00x | -- | $127.96K |
LBTIUSLithium & Boron Technology, Inc. | -- | -- | $18.60K |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
